Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 2063 results found since Jan 2013.
Factors associated with pneumococcal vaccine uptake among vulnerable older adults in the United States primary care setting
This study assessed factors associated with having gotten a pneumococcal vaccine among vulnerable adults aged 50 and older. This study used the 2018 Medical Expenditure Panel Survey nationally representative dataset. Eligible individuals were aged 50-64 with an 'at risk' health condition or ≥65 years and had a primary care provider as their usual source of care (N = 3,760). Binary logistic regression was used to test factors (identified from literature) for a significant association with getting the pneumococcal vaccine. Factors with significant associations were entered into an adjusted multivariable logistic regression...
Source: Herpes - October 13, 2022 Category: Infectious Diseases Authors: Megan Whaley David R Axon Source Type: research
An Unusual Case of Arm Pain in a Young Soccer Player: Herpes Zoster in the Pediatric Athlete
Curr Sports Med Rep. 2022 Nov 1;21(11):386-390. doi: 10.1249/JSR.0000000000001005.ABSTRACTHerpes zoster (HZ), shingles, is caused by the varicella-zoster virus (VZV). HZ develops as a reactivation of latent VZV and is characterized by a painful, vesicular rash typically manifesting in a dermatomal distribution on the arms, trunk or face. HZ occurs in individuals who had primary VZV disease (chickenpox) as a child or in those who have received live, attenuated VZV vaccine. HZ is common in the elderly and the immunocompromised, with age being the single greatest risk factor. The incidence of HZ in children is 74/100,000 pers...
Source: Herpes - November 7, 2022 Category: Infectious Diseases Authors: James MacDonald Joy Mosser-Goldfarb Cristina Tomatis Souverbielle Steven Cuff Source Type: research
Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.
CONCLUSION: Most studies included in this review shows that vaccination against HZ is likely to be cost-effective. Future research addressing key model parameters and cost-effectiveness studies in other parts of the world are needed.
PMID: 24534737 [PubMed - as supplied by publisher]
Source: Vaccine - February 14, 2014 Category: Allergy & Immunology Authors: Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ Tags: Vaccine Source Type: research
Herpes Zoster.
This article summarizes the background, evidence, and guidelines for the diagnosis, complications, treatment, and prevention of herpes zoster. Diagnosis of challenging cases relies on polymerase chain reaction as the preferred test. Treatment focuses on optimal use of antiviral therapy and analgesics. Prevention emphasizes utilization of a new recombinant zoster vaccine, which reduces the incidence of herpes zoster by more than 90% and is preferred to the live attenuated herpes zoster vaccine.
PMID: 30083718 [PubMed - in process]
Source: Annals of Internal Medicine - August 7, 2018 Category: Internal Medicine Authors: Schmader K Tags: Ann Intern Med Source Type: research
Promoting Adult Immunization Using Population-Based Data for a Composite Measure
ConclusionsSurvey-based vaccination data may under- or over-estimate coverage, but most adults require at least one additional vaccination by any metric. A composite measure provides a single focal point to promote adherence to standards of care.
Source: American Journal of Preventive Medicine - August 19, 2018 Category: International Medicine & Public Health Source Type: research
A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
Conclusion: Vaccination with RZV yields cost-effectiveness ratios lower than those for many recommended adult vaccines, including ZVL. Results are robust over a wide range of plausible values.
Primary Funding Source: Centers for Disease Control and Prevention.
PMID: 30776797 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - February 19, 2019 Category: Internal Medicine Authors: Prosser LA, Harpaz R, Rose AM, Gebremariam A, Guo A, Ortega-Sanchez IR, Zhou F, Dooling K Tags: Ann Intern Med Source Type: research
COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy-Making
This article further conducts comparisons between different COVID-19 vaccine platforms based on their technology, production requirement, immune response, advantages and disadvantages. Efficacy and safety of COVID-19 vaccines in frail older people in long-term care settings have been reviewed. Challenges of COVID-19 vaccine development and policy-making for vaccination strategies in older adults have been addressed.
Source: Clinics in Geriatric Medicine - March 20, 2022 Category: Geriatrics Authors: Chih-Kuang Liang, Wei-Ju Lee, Li-Ning Peng, Lin-Chieh Meng, Fei-Yuan Hsiao, Liang-Kung Chen Source Type: research
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
The objective of this study was to critically review the cost-effectiveness (CE) of the recombinant zoster vaccine (RZV) against herpes zoster (HZ). A literature review was conducted in PubMed, Embase, and Cochrane between January 1, 2017, and February 28, 2022, and on select public healthcare agency websites to identify and collect data from CE studies comparing RZV to zoster vaccine live (ZVL) or to no vaccination. Study characteristics, inputs, and outputs were collected. The overall CE of RZV was assessed. RZV vaccination against HZ is cost-effective in 15 out of 18 studies included in the present review. Varying incre...
Source: Herpes - March 14, 2023 Category: Infectious Diseases Authors: Nikolaos Giannelos Cheryl Ng Desmond Curran Source Type: research
Relationship of Income and Health Care Coverage to Receipt of Recommended Clinical Preventive Services by Adults - United States, 2011-2012.
This report summarizes the findings for six services covered by the Affordable Care Act. Among the six services examined, three were received by less than half of the persons for whom they were recommended (testing for human immunodeficiency virus [HIV] and vaccination for influenza and zoster [shingles]). Having health insurance or a higher income was associated with higher rates of receiving these preventive services, affirming findings of previous studies. Securing health insurance coverage might be an important way to increase receipt of clinical preventive services, but insurance coverage is not all that is needed to ...
Source: MMWR Morb Mortal Wkl... - August 8, 2014 Category: Epidemiology Authors: Fox JB, Shaw FE, Office of Health System Collaboration, Office of the Associate Director for Policy, CDC Tags: MMWR Morb Mortal Wkly Rep Source Type: research
Some healthcare can safely wait (and some can ’t)
Among the many remarkable things that have happened since the COVID-19 pandemic began is that a lot of our usual medical care has simply stopped.
According to a recent study, routine testing for cervical cancer, cholesterol, and blood sugar is down nearly 70% across the country. Elective surgeries, routine physical examinations, and other screening tests have been canceled or rescheduled so that people can stay at home, avoid being around others who might be sick, and avoid unknowingly spreading the virus. Many clinics, hospitals, and doctors’ offices have been closed for weeks except for emergencies. Even if these facil...
Source: Harvard Health Blog - May 20, 2020 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Health Health care Healthy Aging Men's Health Women's Health Source Type: blogs
A Review of Racial and Ethnic Disparities in Immunizations for Elderly Adults
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211014071. doi: 10.1177/21501327211014071.ABSTRACTVaccine preventable diseases are responsible for a substantial degree of morbidity in the United States as over 18 million annual cases of vaccine preventable disease occur in the U.S. annually. The morbidity due to vaccine preventable disease is disproportionately borne by adults as over 99% of the deaths due to vaccine preventable diseases occur within adults, and national data indicates that there racial disparities in the receipt of vaccines intended for elderly adults. A literature review was conducted by using the ...
Source: Primary Care - May 25, 2021 Category: Primary Care Authors: Oluchi Elekwachi La'Marcus T Wingate Veronica Clarke Tasker Lorraine Aboagye Tadesse Dubale Dagmawit Betru Razan Algatan Source Type: research
